Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21497043rdf:typepubmed:Citationlld:pubmed
pubmed-article:21497043lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0019080lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0004238lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0042971lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C1705413lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0332257lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:21497043lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:21497043pubmed:issue25lld:pubmed
pubmed-article:21497043pubmed:dateCreated2011-6-17lld:pubmed
pubmed-article:21497043pubmed:abstractTextThe purpose of this study was to evaluate the prognostic value of plasma von Willebrand factor (vWF) levels and fibrin d-dimer in a large cohort of anticoagulated permanent atrial fibrillation (AF) patients.lld:pubmed
pubmed-article:21497043pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:languageenglld:pubmed
pubmed-article:21497043pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21497043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21497043pubmed:statusMEDLINElld:pubmed
pubmed-article:21497043pubmed:monthJunlld:pubmed
pubmed-article:21497043pubmed:issn1558-3597lld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:XXXlld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:LipGregory...lld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:MarínFrancisc...lld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:RoldánVanessa...lld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:ValdésMariano...lld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:Hernández-Rom...lld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:MuiñaBegoñaBlld:pubmed
pubmed-article:21497043pubmed:authorpubmed-author:TorregrosaJos...lld:pubmed
pubmed-article:21497043pubmed:copyrightInfoCopyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21497043pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21497043pubmed:day21lld:pubmed
pubmed-article:21497043pubmed:volume57lld:pubmed
pubmed-article:21497043pubmed:ownerNLMlld:pubmed
pubmed-article:21497043pubmed:authorsCompleteYlld:pubmed
pubmed-article:21497043pubmed:pagination2496-504lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:meshHeadingpubmed-meshheading:21497043...lld:pubmed
pubmed-article:21497043pubmed:year2011lld:pubmed
pubmed-article:21497043pubmed:articleTitlePlasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.lld:pubmed
pubmed-article:21497043pubmed:affiliationHematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain.lld:pubmed
pubmed-article:21497043pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21497043pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21497043lld:pubmed